This article was originally published in The Rose Sheet
The European Parliament's Committee on the Environment, Public Health and Food Safety has voted to strengthen the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) legislation during a meeting Oct. 10. The vote passed with 42 members in favor, 12 opposed and six abstentions. Amendments to the legislation include establishing a quality mark for REACH-compliant products, increased focus on alternatives to animal testing and a requirement for substituting compounds deemed "the most hazardous substances" with less toxic ingredients. REACH will undergo a deliberation in the near term before the entire Parliament before it is reviewed by the EU Council of Ministers. Slated to go into effect in the first quarter of next year, REACH requires importers and manufacturers of more than one ton of chemical per year to register with a European chemicals agency. A proposal for the legislation was overhauled in 2003 to reduce burdens on downstream users (1"The Rose Sheet" Nov. 3, 2003, p. 11)...
You may also be interested in...
The European Commission's 1chemical testing proposal released Oct. 29 includes provisions to exempt certain polymers and reduce the burden on downstream users in an effort to address industry concerns
US Regulatory Roundup, June 2020: FDA Talks QSR Redo; ISO Risk Standard Gets Companion Doc; Experts Predict Recalls Surge; And More
News out of the US FDA on the harmonization of its Quality System Regulation with ISO 13485, as well as stories on a new ISO technical report on risk management and a warning from experts about probable recalls because of the COVID-19 pandemic, were of most interest to our readers last month. Here are June’s 10 most popular US regulation and policy stories from Medtech Insight.
The Bayesian adaptive trial design helped slash the Phase I time for Ridgeback’s drug, which could provide a pill-based alternative to Gilead’s remdesivir for COVID-19 patients.